Interferon gamma receptor 2 also known as IFN-γR2 is a protein which in humans is encoded by the IFNGR2 gene.[5]
Function
This gene (IFNGR2) encodes the non-ligand-binding beta chain of the gamma interferon receptor. Human interferon-gamma receptor is a multimer of two IFN-γR1 chains (encoded by IFNGR1) and two IFN-γR2 chains.[6]
Clinical significance
Defects in IFNGR2 are a cause of autosomal recessive mendelian susceptibility to mycobacterial disease (MSMD), also known as familial disseminated atypical mycobacterial infection.[7]
All known mutations in IFNGR2 are collected in the IFNGR2 mutation database.[8]
References
- ^ a b c ENSG00000262795 GRCh38: Ensembl release 89: ENSG00000159128, ENSG00000262795 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000022965 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ Luster AD, Weinshank RL, Feinman R, Ravetch JV (August 1988). "Molecular and biochemical characterization of a novel gamma-interferon-inducible protein". J. Biol. Chem. 263 (24): 12036–43. doi:10.1016/S0021-9258(18)37889-X. PMID 3136170.
- ^ "Entrez Gene: IFNGR2".
- ^ Al-Muhsen S, Casanova JL (December 2008). "The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases". J. Allergy Clin. Immunol. 122 (6): 1043–51, quiz 1052–3. doi:10.1016/j.jaci.2008.10.037. PMID 19084105.
- ^ "All genes - Global Variome shared LOVD".
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
|
|---|
| Chemokine | |
|---|
| CSF | |
|---|
| Interferon | | IFNAR (α/β, I) |
- Agonists: Albinterferon
- Interferon alpha (interferon alfa, IFN-α)
- Interferon alfa (IFNA1, IFNA2, IFNA4, IFNA5, IFNA6, IFNA7, IFNA8, IFNA10, IFNA13, IFNA14, IFNA16, IFNA17, IFNA21)
- Interferon alfa 2a
- Interferon alfa 2b
- Interferon alfa n1
- Interferon alfacon-1
- Interferon alpha-n3
- Interferon beta (IFN-β) (IFNB1, IFNB3)
- Interferon beta 1a
- Interferon beta 1b
- Interferon kappa (IFN-ε/κ/τ/ζ, IFNK)
- Interferon omega (IFN-ω, IFNW1)
- Peginterferon alfa-2a
- Peginterferon alfa-2b
- Antibodies: Anifrolumab
- Faralimomab
- MEDI-545
- Rontalizumab
- Sifalimumab
- Decoy receptors: Bifarcept
|
|---|
| IFNGR (γ, II) |
- Antibodies: Emapalumab
- Fontolizumab
|
|---|
| IFNLR (λ, III) |
- See IL-28R (IFNLR) here instead.
|
|---|
|
|---|
| Interleukin | |
|---|
| TGFβ | |
|---|
| TNF | |
|---|
| Others | JAK (inhibitors) | | JAK1 |
- Abrocitinib
- Baricitinib
- Deuruxolitinib
- Filgotinib
- Momelotinib
- Oclacitinib
- Peficitinib
- Ruxolitinib
- Tofacitinib (tasocitinib)
- Upadacitinib
|
|---|
| JAK2 |
- Atiprimod
- AZD-1480
- Baricitinib
- CHZ868
- Cucurbitacin I (elatericin B, JSI-124)
- CYT387
- Deuruxolitinib
- Lestaurtinib
- NSC-7908
- NSC-33994
- Pacritinib
- Peficitinib
- Ruxolitinib
- SD-1008
- Tofacitinib (tasocitinib)
|
|---|
| JAK3 |
- Cercosporamide
- Decernotinib (VX-509)
- Peficitinib
- Ritlecitinib
- TCS-21311
- Tofacitinib (tasocitinib)
- WHI-P 154
- ZM-39923
- ZM-449829
|
|---|
| TYK2 | |
|---|
|
|---|
| Others |
- Additional cytokine receptor modulators: Emfilermin
- Lestaurtinib
- Midostaurin
- Quizartinib
- Sorafenib
- Sunitinib
|
|---|
|
|---|